Molecular predictors and immunomodulatory role of dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with extensive stage small cell lung cancer

被引：0
|
作者：
Chiang, Anne C.
Asghari, Hossein
Ashley, Kerryan
Gettinger, Scott N.
Goldberg, Sarah B.
Herbst, Roy S.
Wilson, Frederick Hugh
Newton, Benjamin Robert
Cohenuram, Michael Keith
Sabbath, Kert D.
Talsania, Ashita D.
Russo, Armand Vincent
Schultz, Eric
Skrzypczak, Stan
Kingsford, Carl
Schalper, Kurt A.
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Ocean Genom, Pittsburgh, PA USA
[3] Yale Univ, Dept Pathol, New Haven, CT USA
[4] Yale Sch Med, New Haven, CT USA
[5] Yale Canc Ctr, New Haven, CT USA
[6] Smilow Canc Hosp Yale New Haven, Yale Sch Medicinel, Yale Canc Ctr, New Haven, CT USA
[7] Yale Univ, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8597
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer
    Zhu, Yan-Juan
    Zhang, Hai-Bo
    Liu, Yi-Hong
    Bai, Jian-Ping
    Li, Yong
    Liu, Li-Rong
    Qu, Yan-Chun
    Qu, Xin
    Chen, Xian
    ONCOLOGY LETTERS, 2017, 14 (01) : 655 - 664
  • [22] Role of thoracic radiation in extensive stage small cell lung cancer: a NCDB analysis
    Takefumi Komiya
    Emily Powell
    Shinkichi Takamori
    Medical Oncology, 2021, 38
  • [23] The Role of Immunotherapy in Extensive Stage Small-Cell Lung Cancer: A Review of the Literature
    Tsiouprou, Ioanna
    Zaharias, Athanasios
    Spyratos, Dionisios
    CANADIAN RESPIRATORY JOURNAL, 2019, 2019
  • [24] Phase I/II trial of anti-PD-1 checkpoint inhibitor nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for patients with extensive-stage small cell lung cancer
    Kim, Chul
    Subramaniam, Deepa Suresh
    Liu, Stephen V.
    Giaccone, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer
    Feldman, Hope
    Sepesi, Boris
    Leung, Cheuk H.
    Lin, Heather
    Weissferdt, Annikka
    Pataer, Apar
    William Jr, William N.
    Walsh, Garrett L.
    Rice, David C.
    Roth, Jack A.
    Mehran, Reza J.
    Hofstetter, Wayne L.
    Antonoff, Mara B.
    Rajaram, Ravi
    Gibbons, Don L.
    Lee, J. Jack
    Heymach, John V.
    Vaporciyan, Ara A.
    Swisher, Stephen G.
    Cascone, Tina
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 167 (04):
  • [26] Patterns of disease progression to checkpoint inhibitor immunotherapy in patients with stage IV non-small cell lung cancer
    Attia, Christina G.
    Fei, Naomi
    Almubarak, Mohammed
    Ma, Patrick C.
    Mattes, Malcolm D.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2020, 64 (06) : 866 - 872
  • [27] Significant Tumor Regression and Toxicity with Nivolumab Plus Ipilimumab in Small Cell Lung Cancer Patients Following Radiation
    Gilmore, B.
    Batus, M.
    Fidler, M. J.
    Marwaha, G.
    Bonomi, P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S797 - S797
  • [28] Patterns of Disease Progression to Checkpoint Inhibitor Immunotherapy in Patients with Stage IV Non-Small Cell Lung Cancer
    Attia, C. G.
    Fei, N.
    Almubarak, M.
    Ma, P.
    Wen, S.
    Mattes, M. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E91 - E92
  • [29] A Prospective Single Arm Phase I/II Study: Consolidative Ipilimumab and Nivolumab with Thoracic Radiotherapy after Platinum Based Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer
    Perez, B. A.
    Kim, S.
    Dilling, T. J.
    Latifi, K.
    Rose, T.
    Lannon, A.
    Macmillan, G.
    Grass, G. D.
    Chiappori, A.
    Haura, E. B.
    Creelan, B.
    Gray, J.
    Tanvetyanon, T.
    Shafique, M.
    Saltos, A. N.
    Rosenberg, S. A.
    Schell, M.
    Antonia, S. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S36 - S36
  • [30] Clinical and laboratory predictors of immune checkpoint inhibitor efficacy in non-small cell lung cancer
    Christopoulos, P.
    Kohlhaeufl, J.
    Bozorgmehr, F.
    Kuon, J.
    Schneider, M.
    Neumann, O.
    Liersch, S.
    Heussel, C.
    Winter, H.
    Herth, F.
    Rieken, S.
    Muley, T.
    Meister, M.
    Bischoff, H.
    Lasitschka, F.
    Stenzinger, A.
    Thomas, M.
    ANNALS OF ONCOLOGY, 2018, 29
12345